This has the capability of running. Its just waiting for the push. Check out what it did back in January of 09. It ran easy from levels lower than this. 500+%.

Here is a paragraph from advancedcell.com ACTC's website about the stem cell research for retinal disorders.

"The Company is in the final stages of moving toward the initiation of Phase I clinical trials for its Retinal Pigment Epithelial (RPE) program which addresses a number of retinal degenerative disorders. ACT has published positive data from animal studies for the RPE cell program – completed in collaboration with the Casey Eye Institute at Oregon Health and Science University (OHSU) – as well as recently announced promising results – also in collaboration with OHSU- from GLP Safety Studies and long-term efficacy studies for the RPE therapy. Currently ACT is finalizing preclinical studies for the bio-distribution of RPE and expects spiking studies to be finished in the second half of 2009. ACT expects to file the RPE program IND by the end of the year."

They have filed (Nov 09) and are waiting to hear back from the FDA.

The CEO was recently a keynote speaker at the Insurance Linked Securities Summit at the end of January in NYC.